Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-000959
Filing Date
2025-03-20
Accepted
2025-03-20 17:14:19
Documents
3
Period of Report
2025-03-20

Document Format Files

Seq Description Document Type Size
1 6-K zk2532900.htm 6-K 10787
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 12726
3 image00001.jpg GRAPHIC 9238
  Complete submission text file 0001178913-25-000959.txt   37588
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 25757754
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)